← vista completa

Publicado el 1 de marzo de 2009 | http://doi.org/10.5867/medwave.2009.03.3832

Innovaciones en el tratamiento antihipertensivo en el adulto mayor

Innovations in hypertension treatment in the elderly

Homero Gac Espínola

Esta obra de Medwave está bajo una licencia Creative Commons Atribución-NoComercial 3.0 Unported. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

Autores

Homero Gac Espínola

Pontificia Universidad Católica de Chile, Santiago, Chile

Figures

Article has no figures.

Foro

No hay mensajes

Historial

Citación Gac Espínola H. Innovations in hypertension treatment in the elderly. Medwave 2009;9(03):e3832 doi: 10.5867/medwave.2009.03.3832

Envío 01/01/1970

Aceptación 01/01/1970

Publicación 01/03/2009

Métricas

Vistas en HTML

150

Descargas en PDF

15

Total

165

% Descargas en PDF

10%

Ver detalle

Notas

Referencias

  1. Franklin SS. Ageing and hypertension: the assessment of blood pressure indices in predicting coronary heart disease. J Hypertens Suppl. 1999 Dec;17(5):S29-36. | PubMed
  2. Farsang C, Sleight P. Isolated systolic hypertension: cardiovascular risk and treatment benefits. J Hypertens. 2001 Dec;19(12):2279-81. | CrossRef | PubMed
  3. Lapuerta P, L’Italien G. K029: Population blood pressure control in patients with diabetes and congestive heart failure. Am J Hypertens. 1999 Apr; 12:92A. | CrossRef | Link
  4. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension. 1995 Jul;26(1):60-9. | CrossRef | PubMed
  5. Whyte JL, Lapuerta P, L'Italien GJ, Franklin SS. The challenge of controlling systolic blood pressure: data from the National Health and Nutrition Examination Survey (NHANES III), 1988--1994. J Clin Hypertens (Greenwich). 2001 Jul-Aug;3(4):211-6. | CrossRef | PubMed
  6. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension. 2004 Jan;43(1):10-7. Epub 2003 Nov 24. | CrossRef | PubMed
  7. Lawes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, Rodgers A. Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burden. J Hypertens. 2006 Mar;24(3):423-30. | CrossRef | PubMed
  8. Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH Jr, Kostis JB, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA. 1998 Mar 18;279(11):839-46. | CrossRef | PubMed
  9. Beyer FR, Dickinson HO, Nicolson DJ, Ford GA, Mason J. Combined calcium, magnesium and potassium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev. 2006 Jul 19;3. | PubMed
  10. He FJ, MacGregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev. 2004;(3) | PubMed
  11. Dickinson HO, Nicolson DJ, Cook JV, Campbell F, Beyer FR, Ford GA, et al. Calcium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev. 2006 Apr 19;(2) | PubMed
  12. Dickinson HO, Nicolson DJ, Campbell F, Cook JV, Beyer FR, Ford GA, et al. Magnesium supplementation for the management of essential hypertension in adults. Cochrane Database Syst Rev. 2006 Jul 19;3. | PubMed
  13. Dickinson HO, Campbell F, Beyer FR, Nicolson DJ, Cook JV, Ford GA, et al. Relaxation therapies for the management of primary hypertension in adults. Cochrane Database Syst Rev. 2008 Jan 23;(1) | PubMed
  14. Staessen JA, Gasowski J, Wang JG, Thijs L, Den Hond E, Boissel JP, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet. 2000 Mar 11;355(9207):865-72. | CrossRef | PubMed
  15. Moser M, Cushman WC, Ziegler MG. The treatment of hypertension in the elderly. J Clin Hypertens (Greenwich). 2008 Jan;10(1):58-68. | CrossRef | PubMed
  16. Forette F, Seux ML, Staessen JA, Thijs L, Birkenhäger WH, Babarskiene MR, et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 1998 Oct 24;352(9137):1347-51. | CrossRef | PubMed
  17. McGuinness B, Todd S, Passmore P, Bullock R. The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease. Cochrane Database Syst Rev. 2006 Apr 19;(2) | PubMed
  18. Oates DJ, Berlowitz DR, Glickman ME, Silliman RA, Borzecki AM. Blood pressure and survival in the oldest old. J Am Geriatr Soc. 2007 Mar;55(3):383-8. | CrossRef | PubMed
  19. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008 May 1;358(18):1887-98. Epub 2008 Mar 31. | CrossRef | PubMed
  20. Sica DA. Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats. Drugs. 2002;62(3):443-62. | CrossRef | PubMed
  21. Bakris GL. The importance of blood pressure control in the patient with diabetes. Am J Med. 2004 Mar 8;116 Suppl 5A:30S-38S. | CrossRef | PubMed
  22. Lindholm LH, Carlberg B, Samuelsson O. Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet. 2005 Oct 29-Nov 4;366(9496):1545-53. | CrossRef | PubMed
  23. Wing LM, Reid CM, Ryan P, Beilin LJ, Brown MA, Jennings GL, et al. A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med. 2003 Feb 13;348(7):583-92. | CrossRef | PubMed
  24. Strauss MH, Hall AS. Angiotensin receptor blockers may increase risk of myocardial infarction: unraveling the ARB-MI paradox. Circulation. 2006 Aug 22;114(8):838-54. | CrossRef | PubMed
  25. Tsuyuki RT, McDonald MA. Angiotensin receptor blockers do not increase risk of myocardial infarction. Circulation. 2006 Aug 22;114(8):855-60. | CrossRef | PubMed
  26. Volpe M, Mancia G, Trimarco B. Angiotensin II receptor blockers and myocardial infarction: deeds and misdeeds. J Hypertens. 2005 Dec;23(12):2113-8. | CrossRef | PubMed
  27. Verdecchia P, Angeli F, Gattobigio R, Reboldi GP. Do angiotensin II receptor blockers increase the risk of myocardial infarction? Eur Heart J. 2005 Nov;26(22):2381-6. Epub 2005 Aug 4. | CrossRef | PubMed